Wendy Chung is the Chair of Pediatrics at Boston Children’s Hospital/Harvard Medical School. She is a clinical geneticist specializing in neurodevelopmental disorders. Her research extends to the genetic basis of seizures, intellectual disabilities, autism, inherited metabolic conditions, rare disorders and several other diseases including obesity, diabetes, cardiomyopathies, and congenital heart disease.
Eric Marsh is an Attending Physician, Professor of Neurology and Clinical Director of the Neurogenetics Program at the Children’s Hospital of Philadelphia. He is also an Associate Professor of Neurology and Pediatrics at the Perelman School of Medicine, University of Pennsylvania, and the Clinical Director of the Orphan Disease Center at UPenn.
Yael Weiss received an MD at the Hebrew University in Jerusalem and her PhD in molecular genetics at the Weizmann Institute of Science (Rehovot, Israel). She has more than 20 years of industry experience in medical/clinical and business development roles at Genzyme, Merck, and Ultragenyx. In 2020, Yael founded Mahzi Therapeutics to bring therapies to patients with underserved rare genetic neurodevelopmental disorders.